NEWS: Sanders Statement on Eli Lilly’s Decision to Lower the Starter Price of Blockbuster Weight-Loss Drug Zepbound
BURLINGTON, Vt., Aug. 27 – Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), on Tuesday issued the following statement after drugmaker Eli Lilly agreed to significantly lower the list price for the starter dose of its weight loss drug Zepbound: Last month, President Biden and I co-authored an op-ed demanding that Novo